No Data
Cathay Pacific Haitong: The billion-dollar autoimmune sector is undergoing a generational shift as multinational corporations (MNCs) accelerate their efforts to secure the next-generation pipeline.
Self-administered major drugs are an important cornerstone of MNC's existing business; as patents approach expiration, MNCs are accelerating the development of the next generation of self-administered pipelines.
Zhitong HK Stock Investment Diary | April 17
Hong Kong Stock Investment Diary | April 17, 2026
The concept of innovative pharmaceuticals in Hong Kong's stock market rose across the board, with the General Office of the State Council issuing a document to improve the drug pricing mechanism. Citi noted that innovative pharmaceutical companies such as
The concept of innovative pharmaceuticals in Hong Kong stocks rose across the board. As of press time, XtalPi Holdings and Innovent Bio increased by over 4%, Rongchang Bio rose nearly 4%, Sino Biopharm gained more than 3%, 3SBio Inc. rose nearly 3%, while Hengrui Pharma and BeiGene increased by over 2%.
Trump takes action on pharmaceuticals! Import drugs face a maximum tax rate of 100%.
Trump fulfilled his threat by imposing a tariff of up to 100% on certain imported patented drugs. However, giants such as Merck and Eli Lilly and Co had already privately 'negotiated for exemptions.' Who will ultimately bear the brunt?
China Medical System Sets AGM to Approve 2025 Results, Dividend and Share Issuance Mandate
CMS: Annual Report 2025